Basit öğe kaydını göster

dc.contributor.authorAKCAY, T
dc.contributor.authorCAKATAY, Ufuk
dc.contributor.authorTelci, AYŞE GÜL SÜNDÜS
dc.contributor.authorERDOGAN, C
dc.contributor.authorKAYALI, Refik
dc.contributor.authorSIVAS, Ahmet
dc.contributor.authorORHAN, Yusuf
dc.date.accessioned2021-03-06T11:07:42Z
dc.date.available2021-03-06T11:07:42Z
dc.date.issued2000
dc.identifier.citationTelci A. G. S. , CAKATAY U., KAYALI R., ERDOGAN C., ORHAN Y., SIVAS A., AKCAY T., "Oxidative protein damage in plasma of type 2 diabetic patients", HORMONE AND METABOLIC RESEARCH, cilt.32, ss.40-43, 2000
dc.identifier.issn0018-5043
dc.identifier.othervv_1032021
dc.identifier.otherav_ed96b914-1225-4dca-861a-d35a9c6df5a3
dc.identifier.urihttp://hdl.handle.net/20.500.12627/155974
dc.identifier.urihttps://doi.org/10.1055/s-2007-978584
dc.description.abstractIn this study, we evaluated protein oxidation in 84 patients with Type 2 diabetes with no complications and in 61 healthy volunteers who formed the control group, whose ages matched those of the patients. We determined plasma carbonyl and plasma thiol levels as markers of oxidative protein damage and erythrocyte glutathione, plasma ceruloplasmin and transferrin as markers of free radical scavengers. The concentrations (mean +/- SD) of both of plasma carbonyl (1.24 +/- 0.46 vs. 0.72 +/- 0.17 nmole/mg protein; p < 0.0001) and lipid hydroperoxides (1.8 +/- 0.63 vs. 1.3 +/- 0.21 mu mole/l; p < 0.0001) were increased, and the concentration of plasma transferrin (3.85 +/- 0.65 vs, 4.59 +/- 0.79 g/l; p < 0.05) was decreased, respectively, in Type 2 diabetic patients compared with those of the controls. There were no significant differences in the concentrations of plasma thiol (0.0064 +/- 0.001 vs. 0.0068 +/- 0.001 mu mole/mg protein), erythrocyte glutathione (2.54 +/- 0.57 vs. 2.65 +/- 0.56 mg/g Hb), plasma ceruloplasmin (548 +/- 107.30 vs. 609 +/- 93.34 mg/l) between the patients and the controls. These changes observed in diabetic patients contribute to the imbalance in the redox status of the plasma. We attribute this imbalance to oxidative protein damage in Type 2 diabetic patients clinically free of complications.
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectEndokrinoloji ve Metabolizma Hastalıkları
dc.subjectENDOKRİNOLOJİ VE METABOLİZMA
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.titleOxidative protein damage in plasma of type 2 diabetic patients
dc.typeMakale
dc.relation.journalHORMONE AND METABOLIC RESEARCH
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume32
dc.identifier.issue1
dc.identifier.startpage40
dc.identifier.endpage43
dc.contributor.firstauthorID27874


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster